stock decline

DoorDash missed Q4 earnings and revenue expectations, reporting $0.48 EPS versus $0.60 consensus. Stock fell 7% in after-hours trading.

Class action lawsuits filed against Ultragenyx and Mereo after Phase III clinical trials for setrusumab failed. Stock prices plummeted 42% and 88% respectively following the announcement.

Gemini Space Station stock tumbled 12.9% after three senior executives departed and an analyst downgraded the company, citing concerns about operational stability and strategic direction.

uniQure stock plummeted 49% after FDA rejected accelerated approval for gene therapy AMT-130, triggering a class action lawsuit alleging securities fraud.

BellRing Brands faces securities fraud lawsuit for allegedly failing to disclose significant inventory issues. Stock fell 52% during the class period amid operational challenges.

Valaris shares fell 7% as the company delayed earnings due to pending $5.8 billion merger with Transocean. Investor caution reflects uncertainty over merger timing and offshore drilling sector weakness.

Law firm Pomerantz LLP investigates First Western Financial for potential securities violations following earnings miss and 8.81% stock drop on January 23, 2026.

Pomerantz investigates First Citizens BancShares for potential securities fraud following disappointing Q4 earnings and weak guidance, triggering an 8.49% stock decline.

Devon Energy beat earnings and revenue expectations with improved operational efficiency, but shares fell 1.7% in after-hours trading, reflecting broader market concerns beyond quarterly results.

REGENXBIO faces securities lawsuit over alleged false statements about gene therapy safety. Investors have until April 14 deadline to join class action after FDA clinical hold.

Law firm Block & Leviton investigates GEMI for potential securities violations after three senior executives departed amid 10% stock decline and 25% workforce reduction.

Palo Alto Networks shares fell 2.71% despite announcing the Koi acquisition to boost endpoint security. Analysts remain bullish with a Buy rating and $224 price target.

Hycroft Mining shares fell 7.26% due to Asian holiday closures, Fed policy uncertainty, and precious metals volatility. Technical weakness and reduced trading liquidity pressured the mining sector.

Peloton's stock has crashed 97% from peak as subscriber losses mount. Analysts suggest acquisition could be the company's best path forward amid pandemic-era challenges.

Air Industries merges with Tenax Aerospace in restructuring deal. Tenax shareholders gain 95% ownership; Air Industries shareholders diluted to 5%, causing stock to fall 6.58%.

Ashford Capital invests $12.6M in Sportradar despite 26% stock decline, betting on strong operational fundamentals and growth potential in sports analytics.

Meta stock retreated from post-earnings gains despite strong guidance. Billionaire Bill Ackman's fund initiated a $2 billion position, betting on Meta's AI advertising potential.

Nidec's stock plunges 22.7% after announcing accounting irregularities at its China unit. Class action litigation launched investigating potential securities law violations and shareholder damages.

Gagnon Securities sells $7.51M in Freshworks shares, reducing stake to 3.1%. Stock down 60% yearly, but company shows 16% revenue growth and improved profitability.

Barington Companies buys $5.56M stake in Chemed as stock drops 15% YoY, viewing depressed valuation as opportunity in healthcare-services company.